<?xml version="1.0"?>
<?xml-stylesheet type="text/xsl" href="billres.xsl"?>
<!DOCTYPE bill PUBLIC "-//US Congress//DTDs/bill.dtd//EN" "bill.dtd">
<bill bill-stage="Introduced-in-Senate" dms-id="A1" public-private="public">
	<metadata xmlns:dc="http://purl.org/dc/elements/1.1/">
<dublinCore>
<dc:title>113 S557 IS: Medication Therapy Management Empowerment Act of 2013</dc:title>
<dc:publisher>U.S. Senate</dc:publisher>
<dc:date>2013-03-13</dc:date>
<dc:format>text/xml</dc:format>
<dc:language>EN</dc:language>
<dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
</dublinCore>
</metadata>
<form>
		<distribution-code display="yes">II</distribution-code>
		<congress>113th CONGRESS</congress>
		<session>1st Session</session>
		<legis-num>S. 557</legis-num>
		<current-chamber>IN THE SENATE OF THE UNITED STATES</current-chamber>
		<action>
			<action-date date="20130313">March 13, 2013</action-date>
			<action-desc><sponsor name-id="S320">Mrs. Hagan</sponsor> (for herself,
			 <cosponsor name-id="S260">Mr. Roberts</cosponsor>, <cosponsor name-id="S332">Mr. Franken</cosponsor>, <cosponsor name-id="S311">Ms.
			 Klobuchar</cosponsor>, <cosponsor name-id="S257">Mr. Johnson of South
			 Dakota</cosponsor>, and <cosponsor name-id="S307">Mr. Brown</cosponsor>)
			 introduced the following bill; which was read twice and referred to the
			 <committee-name committee-id="SSFI00">Committee on
			 Finance</committee-name></action-desc>
		</action>
		<legis-type>A BILL</legis-type>
		<official-title>To amend title XVIII of the Social Security Act to
		  improve access to medication therapy management under part D of the Medicare
		  program. </official-title>
	</form>
	<legis-body>
		<section id="S1" section-type="section-one"><enum>1.</enum><header>Short
			 title</header><text display-inline="no-display-inline">This Act may be cited as
			 the <quote><short-title>Medication Therapy Management
			 Empowerment Act of 2013</short-title></quote>.</text>
		</section><section id="idD72E1B754F7B4445876C091905CC8EB4"><enum>2.</enum><header>Improved access
			 to medication therapy management under part D of the Medicare
			 program</header><text display-inline="no-display-inline">Section 1860D–4(c)(2)
			 of the Social Security Act (<external-xref legal-doc="usc" parsable-cite="usc/42/1395w-104">42 U.S.C. 1395w–104(c)(2)</external-xref>) is amended—</text>
			<paragraph id="id3222B6E3573540C69951139779AA0A5E"><enum>(1)</enum><text>in subparagraph
			 (A)(ii)(I), by striking <quote>have</quote> and inserting <quote>subject to
			 subparagraph (H), have</quote>; and</text>
			</paragraph><paragraph id="id77EBCD6BD2CA463E8F4342F4C9E5019C"><enum>(2)</enum><text>by adding at the
			 end the following new subparagraph:</text>
				<quoted-block display-inline="no-display-inline" id="id25B1EE49D654460295202132ABFD24DF" style="OLC">
					<subparagraph id="id4A6607EEA4D544D6A938BF9289B2B95D"><enum>(H)</enum><header>Expansion of
				definition of targeted beneficiary the expansion reduces spending</header>
						<clause id="id8F21801ABE9749B4A13B8D7B324BADA5"><enum>(i)</enum><header>CMS actuary
				report</header><text>Not later than January 1, 2014, the Chief Actuary of the
				Centers for Medicare &amp; Medicaid Services (in this subparagraph referred to
				as the <quote>Chief Actuary</quote>) shall submit to the Secretary and to
				Congress a report on whether or not the expansion described in clause (ii)
				would, if implemented, reduce expenditures under this title. If the Chief
				Actuary determines that such expansion would reduce spending under this title,
				such report shall include a certification of such determination.</text>
						</clause><clause id="id2A2425C895B644FC98B6E6077D16D0D6"><enum>(ii)</enum><header>Expansion
				described</header><text>The expansion described in this clause is an expansion
				of the definition of targeted beneficiary under subparagraph (A)(ii) by
				applying subclause (I) of such subparagraph as if the following were inserted
				before the semicolon at the end: <quote>or a single chronic disease that
				accounts for high spending under this title, including diabetes, hypertension,
				heart failure, dyslipidemia, respiratory disease (such as asthma, chronic
				obstructive pulmonary disease, or chronic lung disorders), bone
				disease-arthritis (such as osteoporosis or osteoarthritis), rheumatoid
				arthritis, and mental health (such as depression, schizophrenia, or bipolar
				disorder)</quote>.</text>
						</clause><clause id="id3E2BE93028CA41F18325EB3A4F7842C3"><enum>(iii)</enum><header>Application
				if the Chief Actuary determines that the expansion reduces
				spending</header><text>If the report under clause (i) contains the
				certification described in such clause, the following rules shall apply:</text>
							<subclause id="idB000C3507FFF4608928C2D8908550C36"><enum>(I)</enum><header>Implementation
				of expansion</header><text>Subject to subclause (III), effective with respect
				to plan years beginning on or after January 1, 2015, subparagraph (A)(ii)(I)
				shall be applied to include the expansion described in clause (ii).</text>
							</subclause><subclause id="id1A258FF1EC1344DBA5167EA2ACCA502C"><enum>(II)</enum><header>Updated CMS
				actuary report based on implementation</header><text>Not later than March 1,
				2020, the Chief Actuary shall submit to the Secretary and to Congress a report
				on the implementation of the expansion under subclause (I). Such report shall
				include an analysis of whether or not such expansion reduces spending under
				this title.</text>
							</subclause><subclause id="idB29E6C35A64442CFB95E30BC3A3EC78D"><enum>(III)</enum><header>Authority to
				terminate expansion if the expansion does not reduce spending</header><text>If
				the Chief Actuary determines in the report under subclause (II) that the
				expansion does not reduce spending under this title, the Secretary may,
				effective with respect to plan years beginning on or after January 1, 2021,
				apply subparagraph (A)(ii)(I) as if this subparagraph had never been enacted.
				In making the determination under the preceding sentence, the Secretary shall
				take into account whether such expansion improves the quality of care furnished
				to, and the health outcomes of, individuals eligible for services under a
				medication therapy management program by reason of such
				expansion.</text>
							</subclause></clause></subparagraph><after-quoted-block>.</after-quoted-block></quoted-block>
			</paragraph></section></legis-body>
</bill>


